Skip to main content

Table 5 The ratios of scenarios satisfied the clinical specifications that the 100% target volume being above the 100% or 95% prescription dose for all patients

From: Evaluation of OAR dose sparing and plan robustness of beam-specific PTV in lung cancer IMRT treatment

Patient nos. General PTV plan (%) BSPTV plan (%)
100% prescription dose 95% prescription dose 100% prescription dose 95% prescription dose
1 50 100 50 100
2 50 100 50 100
3 100 100 50 100
4 100 100 100 100
5 67 83 50 83
6 50 100 50 100
7 100 100 100 100
8 67 100 67 100
9 83 100 67 83
10 100 100 100 100
11 100 100 83 100
12 67 100 50 100
13 17 67 17 67
14 83 100 83 100
15 100 100 100 100